We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+14.27%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$256M
AUM Growth
+$12.2M
Cap. Flow
-$14.2M
Cap. Flow %
-5.52%
Top 10 Hldgs %
47.16%
Holding
248
New
79
Increased
35
Reduced
67
Closed
65

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.6M
2
EOG icon
EOG Resources
EOG
+$2.56M
3
CVX icon
Chevron
CVX
+$2.51M
4
KVUE icon
Kenvue
KVUE
+$1.8M
5
NEE icon
NextEra Energy
NEE
+$1.79M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$3M
2
PPG icon
PPG Industries
PPG
+$2.06M
3
CL icon
Colgate-Palmolive
CL
+$1.74M
4
MCD icon
McDonald's
MCD
+$1.67M
5
RTX icon
RTX Corp
RTX
+$1.53M

Sector Composition

Rank Sector Weight
1 Technology 17.66%
2 Financials 12.3%
3 Healthcare 9.54%
4 Energy 5.49%
5 Consumer Staples 5.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVGO icon
76
Broadcom
AVGO
$1.98T
$623K 0.24%
5,580
+1,740
+45% +$165K
WEX icon
77
WEX
WEX
$6.44B
$618K 0.24%
+3,177
New +$576K
APP icon
78
Applovin
APP
$107B
$607K 0.24%
15,223
+1,714
+13% +$67.2K
WEAV icon
79
Weave Communications
WEAV
$402M
$590K 0.23%
+51,482
New +$456K
DAY
80
DELISTED
Dayforce
DAY
$588K 0.23%
+8,761
New +$598K
SG icon
81
Sweetgreen
SG
$642M
$587K 0.23%
+51,907
New +$546K
PSN icon
82
Parsons
PSN
$5.15B
$585K 0.23%
+9,334
New +$564K
EAT icon
83
Brinker International
EAT
$9.49B
$584K 0.23%
+13,517
New +$486K
ITCI
84
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$583K 0.23%
+8,147
New +$469K
LYFT icon
85
Lyft
LYFT
$6.64B
$583K 0.23%
38,867
-15,570
-29% -$181K
WIX icon
86
WIX.com
WIX
$2.79B
$581K 0.23%
4,726
-1,735
-27% -$167K
DHI icon
87
D.R. Horton
DHI
$42.2B
$574K 0.22%
3,778
-3,188
-46% -$393K
IAS
88
DELISTED
Integral Ad Science
IAS
$569K 0.22%
+39,555
New +$529K
EXAS
89
DELISTED
Exact Sciences
EXAS
$566K 0.22%
7,645
-804
-10% -$52.7K
ALV icon
90
Autoliv
ALV
$8.96B
$564K 0.22%
+5,119
New +$510K
SRPT icon
91
Sarepta Therapeutics
SRPT
$1.92B
$562K 0.22%
+5,832
New +$559K
BRZE icon
92
Braze
BRZE
$3.18B
$560K 0.22%
10,542
-1,782
-14% -$88.1K
OKTA icon
93
Okta
OKTA
$26.1B
$560K 0.22%
6,181
-1,197
-16% -$91.3K
TRUP icon
94
Trupanion
TRUP
$1.34B
$558K 0.22%
18,298
-2,297
-11% -$60.9K
SIBN icon
95
SI-BONE Inc
SIBN
$843M
$556K 0.22%
+26,495
New +$490K
DOCU
96
DocuSign
DOCU
$11.3B
$550K 0.21%
9,253
-3,224
-26% -$148K
RCUS icon
97
Arcus Biosciences
RCUS
$3.66B
$548K 0.21%
28,690
+2,974
+12% +$47.5K
FULT icon
98
Fulton Financial
FULT
$4.65B
$548K 0.21%
+33,271
New +$467K
EGP icon
99
EastGroup Properties
EGP
$10.8B
$541K 0.21%
+2,947
New +$503K
MNDY icon
100
monday.com
MNDY
$3.7B
$541K 0.21%
2,879
-817
-22% -$132K
2 3
4
5 6

Similar funds

CAWM
Capital A Wealth Management New Castle, Pennsylvania $8.94M AUM
AI
Allostery Investments Stamford, Connecticut $7.85M AUM
PC
Prysm Capital Princeton, New Jersey $10.6M AUM 2.38% 1-Year Est. Return
CP
Castalian Partners Excelsior, Minnesota $7.36M AUM
AVM
Altos Ventures Management Burlingame, California $11.7M AUM 182.72% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
NP
Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return
BPWM
Black Point Wealth Management Naples, Florida $3.5M AUM 16.42% 1-Year Est. Return

Alpha DNA Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, Alpha DNA Investment Management held 248 positions worth $256M, up 5% from $244M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Alpha DNA Investment Management withdrew a net $14.2M in Q4 2023, closing 65 positions and reducing 67 holdings. Its most notable exit was Eli Lilly, an estimated $3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Alpha DNA Investment Management opened a new position in Kenvue worth $1.93M.

  • Alpha DNA Investment Management's largest Q4 2023 buy was Kenvue: 89,868 shares worth $1.93M.
  • Alpha DNA Investment Management added most to Microsoft in Q4 2023, an estimated $2.6M increase.
  • Alpha DNA Investment Management's biggest Q4 2023 reduction was PPG Industries, cutting an estimated $2.06M.
  • Alpha DNA Investment Management fully exited Eli Lilly in Q4 2023, selling an estimated $3M.
  • Alpha DNA Investment Management's ten largest holdings make up 47% of its $256M portfolio in Q4 2023.
  • Alpha DNA Investment Management opened 79 new positions and closed 65 in Q4 2023.
  • Alpha DNA Investment Management's portfolio value rose 5% quarter-over-quarter to $256M.

Based on Alpha DNA Investment Management's 13F filing for Q4 2023, filed 12 Feb 2024.